Quent Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Sell
3,000
-1,000
-25% -$41.9K 0.01% 446
2026
Q1
$129K Hold
4,000
0.01% 477
2025
Q4
$168K Buy
+4,000
New +$161K 0.01% 427
2025
Q2
Sell
-11,354
Closed -$337K 1199
2025
Q1
$337K Sell
11,354
-11,118
-49% -$424K 0.04% 176
2024
Q4
$890K Hold
22,472
0.09% 99
2024
Q3
$765K Hold
22,472
0.08% 135
2024
Q2
$487K Hold
22,472
0.05% 173
2024
Q1
$498K Buy
+22,472
New +$548K 0.06% 177
2023
Q3
Sell
-500
Closed -$12.7K 1349
2023
Q2
$12.7K Buy
+500
New +$12.1K ﹤0.01% 886

Other funds holding VCYT

Quent Capital's VCYT Position: Q2 2026 in Review

Quent Capital reduced its Veracyte (VCYT) stake by 25% in Q2 2026, selling an estimated $41.9K and leaving 3,000 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #446.

Quent Capital first reported a position in VCYT in Q2 2023 and has held it in 9 quarters since. The position peaked at $890K in Q4 2024. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Quent Capital held 3,000 shares of Veracyte worth $176K as of Q2 2026.
  • Quent Capital sold 1,000 Veracyte shares in Q2 2026, an estimated $41.9K.
  • Veracyte made up 0.01% of Quent Capital's portfolio in Q2 2026, its #446 holding.
  • Quent Capital first reported a position in Veracyte in Q2 2023 and has held it in 9 quarters since.
  • Quent Capital's Veracyte position peaked at $890K in Q4 2024.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.